Oxford Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-833
Closed -$73K 2023
2019
Q1
$73K Buy
833
+66
+9% +$4.84K ﹤0.01% 1585
2018
Q4
$46K Buy
+767
New +$53.5K ﹤0.01% 1707
2017
Q4
Sell
-1,362
Closed -$140K 1918
2017
Q3
$140K Buy
+1,362
New +$118K ﹤0.01% 1461
2016
Q4
Sell
-383
Closed -$43K 890
2016
Q3
$43K Sell
383
-844
-69% -$116K ﹤0.01% 751
2016
Q2
$129K Buy
1,227
+1,082
+746% +$77.4K ﹤0.01% 722
2016
Q1
$11K Sell
145
-786
-84% -$46.4K ﹤0.01% 784
2015
Q4
$74K Sell
931
-2,652
-74% -$1.31M ﹤0.01% 850
2015
Q3
$2.41M Buy
+3,583
New +$2.55M 0.08% 264
2013
Q3
Sell
-140
Closed -$122K 928
2013
Q2
$122K Buy
+140
New +$118K ﹤0.01% 820

Other funds holding MTEM

Oxford Asset Management's MTEM Position: Q2 2019 in Review

Oxford Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2019, closing a stake of 833 shares — an estimated $73K sold.

Oxford Asset Management first reported a position in MTEM in Q2 2013 and held it in 9 quarters. The position peaked at $2.41M in Q3 2015. 71 funds tracked by Wall St. Rank hold MTEM as of Q2 2019.

  • Oxford Asset Management reported no remaining Molecular Templates, Inc. position as of Q2 2019 after selling out during the quarter.
  • Oxford Asset Management sold 833 Molecular Templates, Inc. shares in Q2 2019, an estimated $73K.
  • Oxford Asset Management first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 9 quarters.
  • Oxford Asset Management's Molecular Templates, Inc. position peaked at $2.41M in Q3 2015.
  • 71 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.